RBC Capital Reiterates Outperform Rating on Neumora Therapeutics (NMRA)
Go back to RBC Capital Reiterates Outperform Rating on Neumora Therapeutics (NMRA)| (NASDAQ: NMRA) | Delayed: 1.14 -0.06 (5%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1.20 | 52 Week High | $ | |||
| Open | $1.20 | 52 Week Low | $ | |||
| Day High | $1.21 | P/E | N/A | |||
| Day Low | $1.12 | EPS | $ | |||
| Volume | 600,811 | |||||
